Treatment options beyond IFN α and NUCs for chronic HBV infection: expectations for tomorrow
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Hepatitis C virus core antigen testing in liver and kidney transplant recipients
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection
Hepatitis B: global scientific development from a critical point of view
Retrospective analysis of total direct medical costs associated with hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey
Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients
Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations
Maternal ABO and rhesus blood group phenotypes and hepatitis B surface antigen carriage
Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes
Development and evaluation of a baseline-event-anticipation score for hepatitis delta
Absence of nonprimate hepacivirus-related genomes in blood donors seroreactive for hepatitis C virus displaying indeterminate blot patterns